Johnson & Johnson stock falls Friday, underperforms market


Shares of Johnson & Johnson
JNJ,

slid 0.64% to $160.47 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index
SPX,

rising 1.15% to 4,357.04 and the Dow Jones Industrial Average
DJIA,

rising 1.43% to 34,326.46. This was the stock’s second consecutive day of losses. Johnson & Johnson closed $19.45 short of its 52-week high ($179.92), which the company reached on August 20th.

The stock underperformed when compared to some of its competitors Friday, as Roche Holding AG Part. Cert.
RHHVF,

rose 1.91% to $372.50, Merck & Co. Inc.
MRK,

rose 8.37% to $81.40, and Pfizer Inc.
PFE,

fell 0.19% to $42.93. Trading volume (8.5 M) eclipsed its 50-day average volume of 5.6 M.


Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.



Read More: Johnson & Johnson stock falls Friday, underperforms market

article_normalC&E Industry News FilterContent TypescorporateCorporate/Industrial NewsFactiva FiltersfallsFinancial PerformanceFridayHealthcareHealthcare/Life Sciencesindustrial newsJNJJohnsonjohnson & johnsonlife sciencesmarketPharmaceuticalsstockunderperforms
Comments (0)
Add Comment